Eppendorf Reference Series 2000 Fixed-volume Pipette, 2,000 l from Eppendorf North America

Products	Eppendorf Reference Series 2000 Fixed-volume Pipette, 2,000 l from Eppendorf North America
Company	Eppendorf North America
Item	Eppendorf Reference Series 2000 Fixed-volume Pipette, 2,000 l
Price
Description	The Eppendorf Reference Series 2000 Pipette is a synonym for pipetting accuracy, a smooth stroke, a compact and robust design, and superior operating comfort. Its single, multifunctional button is used to operate the measuring stroke and blow-out as well as eject the tip. Product features:Eppendorf "pipette/tip" system ensures utmost accuracy and precision. Ejection sleeve can be removed to fit into smaller vessels. Smooth-running piston is corrosion-free and chemically resistant . UV-resistant and completely autoclavable without any impairment of accuracy or precision.
Info	Eppendorf North America One Cantiague Rd. PO Box 1019 Westbury, NY 11590-0207 Customer Service: 800-645-3050 Fax Number: 516-334-7506 Web Site: http://www.eppendorfna.com

NOTE: Price information is approximate list price and actual prices may vary.

TAG: Eppendorf Reference Series Fixed volume Pipette from Eppendorf North America

Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience

Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam

Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies

Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam

Biology Products:

Mouse Anti-IFN-alpha2 Monoclonal Antibody, Fluorescein isothiocyanate (FITC) Conjugated, Clone 225.C from eBioscience Mouse Anti-alpha Sodium Potassium ATPase Monoclonal Antibody, Unconjugated, Clone M7-PB-E9 from Abcam Rabbit Anti-Human SP2 Polyclonal Antibody, Unconjugated from Atlas Antibodies Rabbit Anti-Asparagine synthetase Monoclonal Antibody, Unconjugated, Clone EP282Y from Abcam

(Date:11/5/2009)...ty have developed synthetic molecules capable of e...-infected cells, as well as to prostate cancer cel...al of the American Chemical Society , could lead t... , The molecules called "antibody-recruiting m...iting molecule targeting prostate cancer" (ARM-P) ...

(Date:11/4/2009)...g Beach and Riverside are responsible for a signif...and the true impact of air pollution and ship emis...d, according to researchers at the University of S...pears in an online edition of the American Journa...f all childhood asthma cases in Long Beach and six...

(Date:11/4/2009)...eived more than $10 million in research grants fro...mulus program, bringing thetotal amount of stimulu...n. Thirty-three projects achieved stimulus fundin... , "The university has thoughtfully undertaken a... excellence to federal agency priorities. Through...

Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2 USC study finds big air pollution impacts on local communities 2 OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2 OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3 Zimmer Holdings to Present at Upcoming Investor Conferences 55934 1 DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 1 DIA Conference to Explore The Science and Scope of Personalized Medicine 55930 2 U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 1 U S Labor Department announces dates for 4th annual Drug Free Work Week 55926 2

[1] New synthetic molecules trigger immune response to HIV and prostate cancer [0] USC study finds big air pollution impacts on local communities [0] OU achieves $10 million in stimulus grants for 33 projects on the Norman campus

...nced Identification Systems/Commerc... 28 /PRNewswire-FirstCall/-- Atmel (Nasdaq:,ATML),...ns, announced today,that Kerry Maletsky, Business ...nt "Secure Biometric Co-processor: Solving the Net...on Systems/Commercial Biometrics,Conference in Was...

...MEA spurs IdentiPHI,s company ...tiPHI, Inc., an innovative,leader in enterprise se...sion with the opening of an office in Paris to add...identity and authentication (access,management) pr...ope will enable us to more closely serve our,growi...

...cans are an increasingly used X-ray-based tool for...r organ or tissue. The value of CT scanning to dia...undisputed. But are these scans being used too fre... health consequences of having too many CT scans o... 2007 article in The New England Journal of Medici...

Other Biology News:Atmel's Biometric Co-processor Solution Featured at AIS/CBX 2 IdentiPHI Opens Paris Office to Boost European Sales and Support 2 Columbia researchers: Growth of CT scan use may lead to significant public health problem 2 Columbia researchers: Growth of CT scan use may lead to significant public health problem 3

Atmel's Biometric Co-processor Solution Featured at AIS/CBX IdentiPHI Opens Paris Office to Boost European Sales and Support Columbia researchers: Growth of CT scan use may lead to significant public health problem

(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personali... to take place on February 22-24, 2010 in Philadel...ence we will highlight key issues in forming partn...r experiences. , Minneapo... Arrowhead’s 2010 Personalized Medicine Par...

(Date:11/5/2009)... Nov. 5 DSM Pharmaceutical Product... alliance with Galenix, Saint Jean D,Illac, France... manufacturing partner for Galenix commercial prod... collaborate on business development opportunities...based on the strength of Galenix in drug product d...

(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...

(Date:11/5/2009)...vember 5, 2009 Senomyx, ...proprietary taste receptor-based technologies to d...erage, and ingredient supply industries, today pro...sults for the third quarter ended September 30, 20...ter of 2009, compared to $4.0 million for the thir...

[0] Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference [0] DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix [0] Transgenomic, Inc. Reports Third Quarter 2009 Results [0] SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS